CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism
Conclusion: CD44ICD promotes breast cancer stemness via PFKFB4-mediated glycolysis, and therapies that target PFKFB4 (e.g., 5MPN therapy) may lead to improved outcomes for cancer patients.
Source: Theranostics - Category: Molecular Biology Authors: Ruifang Gao, Dan Li, Jing Xun, Wei Zhou, Jun Li, Juan Wang, Chen Liu, Xiru Li, Wenzhi Shen, Huan Qiao, Dwayne G. Stupack, Na Luo Tags: Research Paper Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Nanotechnology | Stem Cell Therapy | Stem Cells | Transplants